Jessica J. Oliphant

Deputy Director
FDA, NCTR
Benton, Arkansas, United States

Presentation(s):

• FDA Montelukast Working Group Studies: Identification of Off-Target Neurological Receptors and Potential Molecular Mechanisms of Drug-Related Neuropsychiatric Adverse Effects (P208)

  Monday, November 18, 2024
  5:00 PM - 6:30 PM CT

• Hot Topics (S20)

  Wednesday, November 20, 2024
  2:00 PM - 5:00 PM CT

• Neuropsychiatric Concerns and Potential Molecular Mechanisms Associated with Widely Used Medication Montelukast (Singulair®) (S20-4)

  Wednesday, November 20, 2024
  3:45 PM - 4:15 PM CT